Health Outcomes Practice, Kantar Health, Princeton, New Jersey, United States of America.
PLoS One. 2012;7(11):e50553. doi: 10.1371/journal.pone.0050553. Epub 2012 Nov 30.
In order to adequately assess the effectiveness of vaccination in helping to control vaccine-preventable infectious disease, it is important to identify the adherence and uptake of risk-based recommendations.
The current project includes data from five consecutive datasets of the National Health and Wellness Survey (NHWS): 2007 through 2011. The NHWS is an annual, Internet-based health questionnaire, administered to a nationwide sample of adults (aged 18 or older) which included items on vaccination history as well as high-risk group status. Vaccination rates and characteristics of vaccinees were reported descriptively. Logistic regressions were conducted to predict vaccination behavior from sociodemographics and risk-related variables.
The influenza vaccination rate for all adults 18 years and older has increased significantly from 28.0% to 36.2% from 2007 to 2011 (ps<.05). Compared with those not at high risk (25.1%), all high-risk groups were vaccinated at a higher rate, from 36.8% (pregnant women) to 69.7% (those with renal/kidney disease); however, considerable variability among high-risk groups was observed. Vaccination rates among high-risk groups for other vaccines varied considerably though all were below 50%, with the exception of immunocompromised respondents (57.5% for the hepatitis B vaccine and 52.5% for the pneumococcal vaccine) and the elderly (50.4% for the pneumococcal). Multiple risk factors were associated with increased rate of vaccination for most vaccines. Significant racial/ethnic differences with influenza, hepatitis, and herpes zoster vaccination rates were also observed (ps<.05).
Rates of influenza vaccination have increased over time. Rates varied by high-risk status, demographics, and vaccine. There was a pattern of modest vaccination rate increases for individuals with multiple risk factors. However, there were relatively low rates of vaccination for most risk-based recommendations and all fell below national goals.
为了充分评估疫苗接种在帮助控制可预防传染病方面的有效性,重要的是要确定基于风险的建议的依从性和接受度。
本研究包含了国家健康与健康调查(NHWS)连续五个数据集的数据:2007 年至 2011 年。NHWS 是一项年度互联网健康问卷调查,针对全国成年人(18 岁或以上)样本进行,其中包括疫苗接种史和高危群体状况的项目。报告了疫苗接种率和疫苗接种者的特征。使用逻辑回归从社会人口统计学和与风险相关的变量预测疫苗接种行为。
所有 18 岁及以上成年人的流感疫苗接种率从 2007 年至 2011 年从 28.0%显著增加到 36.2%(p<.05)。与非高危人群(25.1%)相比,所有高危人群的接种率均较高,从 36.8%(孕妇)到 69.7%(患有肾脏/肾脏疾病);然而,高危人群之间存在相当大的差异。其他疫苗的高危人群的疫苗接种率差异很大,尽管所有疫苗的接种率均低于 50%,但免疫功能低下的受访者除外(乙型肝炎疫苗为 57.5%,肺炎球菌疫苗为 52.5%)和老年人(肺炎球菌疫苗接种率为 50.4%)。大多数疫苗的疫苗接种率与多种风险因素相关。还观察到流感,肝炎和带状疱疹疫苗接种率的显著种族/民族差异(p<.05)。
流感疫苗接种率随时间推移而增加。接种率因高危状态,人口统计学和疫苗而异。具有多种危险因素的个体的疫苗接种率呈适度增加趋势。但是,大多数基于风险的建议的疫苗接种率相对较低,均低于国家目标。